Abstract
A low‐dose maintenance schedule of Adriamycin was evaluated in six children whose metastatic solid tumors regressed following toxic induction therapy with Adriamycin. Three of these children are now disease‐free more than one year following discontinuation of therapy. Adriamycin can be given on a low‐dose maintenance schedule free from alopecia, fever, stomatitis, myelosuppression and recognizable cardiomyopathy. Further studies of similar schedules are warranted. Copyright © 1977 American Cancer Society
Cite
CITATION STYLE
Hvizdala, E. V., Komp, D. M., & Arnold, J. B. (1977). Low‐dose adriamycin remission maintenance therapy for pediatric solid tumors. Cancer, 39(6), 2411–2414. https://doi.org/10.1002/1097-0142(197706)39:6<2411::AID-CNCR2820390616>3.0.CO;2-3
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
